132 related articles for article (PubMed ID: 10561590)
1. Identification of a CK2 phosphorylation site in mdm2.
Götz C; Kartarius S; Scholtes P; Nastainczyk W; Montenarh M
Eur J Biochem; 1999 Dec; 266(2):493-501. PubMed ID: 10561590
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells.
Hjerrild M; Milne D; Dumaz N; Hay T; Issinger OG; Meek D
Biochem J; 2001 Apr; 355(Pt 2):347-56. PubMed ID: 11284721
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
Kulikov R; Boehme KA; Blattner C
Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
[TBL] [Abstract][Full Text] [Related]
4. The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation.
Guerra B; Götz C; Wagner P; Montenarh M; Issinger OG
Oncogene; 1997 Jun; 14(22):2683-8. PubMed ID: 9178766
[TBL] [Abstract][Full Text] [Related]
5. Wild-type p53 inhibits protein kinase CK2 activity.
Schuster N; Götz C; Faust M; Schneider E; Prowald A; Jungbluth A; Montenarh M
J Cell Biochem; 2001; 81(1):172-83. PubMed ID: 11180407
[TBL] [Abstract][Full Text] [Related]
6. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.
Mayo LD; Donner DB
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11598-603. PubMed ID: 11504915
[TBL] [Abstract][Full Text] [Related]
7. Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1.
Burch LR; Scott M; Pohler E; Meek D; Hupp T
J Mol Biol; 2004 Mar; 337(1):115-28. PubMed ID: 15001356
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2.
Allende-Vega N; McKenzie L; Meek D
Mol Cell Biochem; 2008 Sep; 316(1-2):99-106. PubMed ID: 18548200
[TBL] [Abstract][Full Text] [Related]
9. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of mdm2 at serine 269 impairs its interaction with the retinoblastoma protein.
Götz C; Kartarius S; Schwär G; Montenarh M
Int J Oncol; 2005 Mar; 26(3):801-8. PubMed ID: 15703839
[TBL] [Abstract][Full Text] [Related]
11. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.
Maya R; Balass M; Kim ST; Shkedy D; Leal JF; Shifman O; Moas M; Buschmann T; Ronai Z; Shiloh Y; Kastan MB; Katzir E; Oren M
Genes Dev; 2001 May; 15(9):1067-77. PubMed ID: 11331603
[TBL] [Abstract][Full Text] [Related]
12. The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo.
Shimizu H; Burch LR; Smith AJ; Dornan D; Wallace M; Ball KL; Hupp TR
J Biol Chem; 2002 Aug; 277(32):28446-58. PubMed ID: 11925449
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2.
Allende-Vega N; Dias S; Milne D; Meek D
Mol Cell Biochem; 2005 Jun; 274(1-2):85-90. PubMed ID: 16335531
[TBL] [Abstract][Full Text] [Related]
14. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
[TBL] [Abstract][Full Text] [Related]
15. Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains.
Hay TJ; Meek DW
FEBS Lett; 2000 Jul; 478(1-2):183-6. PubMed ID: 10922493
[TBL] [Abstract][Full Text] [Related]
16. Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory beta-subunit of protein kinase CK2.
Appel K; Wagner P; Boldyreff B; Issinger OG; Montenarh M
Oncogene; 1995 Nov; 11(10):1971-8. PubMed ID: 7478515
[TBL] [Abstract][Full Text] [Related]
17. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.
Unger T; Juven-Gershon T; Moallem E; Berger M; Vogt Sionov R; Lozano G; Oren M; Haupt Y
EMBO J; 1999 Apr; 18(7):1805-14. PubMed ID: 10202144
[TBL] [Abstract][Full Text] [Related]
18. A genetic approach to mapping the p53 binding site in the MDM2 protein.
Freedman DA; Epstein CB; Roth JC; Levine AJ
Mol Med; 1997 Apr; 3(4):248-59. PubMed ID: 9131587
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of the interaction between MDM2 and p53.
Schon O; Friedler A; Bycroft M; Freund SM; Fersht AR
J Mol Biol; 2002 Oct; 323(3):491-501. PubMed ID: 12381304
[TBL] [Abstract][Full Text] [Related]
20. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
